The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria

Journal of Infectious Diseases

Volumn 174, Issue 5, 1996, Pages 1091-1097

  Van Hensbroek, Michaël Boele ^a   Palmer, Ayo ^c   Onyiorah, Emeka ^c   Schneider, Gisela ^c   Jaffar, Shabbar ^c   Dolan, Grainne ^c   Memming, Hannah ^c   Frenkel, Joost ^c   Enwere, Godwin ^c   Bennett, Steve ^c   Kwiatkowski, Dominic ^c   Greenwood, Brian ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; DIAZEPAM; FANSIDAR; PARALDEHYDE; QUININE; QUININE SULFATE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ARTICLE; BRAIN MALARIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GAMBIA; HUMAN; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; SEIZURE; SUPERINFECTION; SURVIVAL; TREATMENT OUTCOME;

EID: 19244362897     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.5.1091     Document Type: Article

References (20)

1. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995;332:1399-404.
2. Kwiatkowski D, Molyneux S, Stephens N, et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 1993;86:91-8.
3. Boele van Hensbroek M, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335: 69-75.
4. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989;320:1586-91.
5. Kwiatkowski D, Hill AVS, Sambou I, et al. TNF concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990;336:1201-4.
6. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
7. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989;341:57-9.
8. Clark IA, Rockett KA, Cowden WB. Proposed link between cytokines, nitric oxide, and human cerebral malaria. Parasitol Today 1991;7: 205-7.
9. Grau GE, Fajardo LF, Piguet PF, Allet BA, Lambent PH, Vassali P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987;237:1210-2.
10. Molyneux ME, Taylor TE, Wirma JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989;71:441-59.
11. Peto R. Clinical trial methodology. Biomedicine Special Issue 1978;28: 24-36.
12. ISIS-4 Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-82.
13. Herve P, Flesch M, Tiberghien P, et al. Phase I-II trial of a monoclonal anti-tumor necrosis factor-α antibody for the treatment of refractory severe acute graft-versus-host disease. Blood 1992;12:3362-8.
14. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-9.
15. Suitters AJ, Foulkes R, Opal SM, et al. Differential effect of isotype on efficacy of anti-tumor necrosis factor-α chimeric antibodies in experimental septic shock. J Exp Med 1994;179:849-56.
16. Di Parra G, Di Parra IG, Monteiro GB, et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 1995; 171:1317-22.
17. Kwiatkowski D, Bates C. Inhibition of tumour necrosis factor production by antimalarial drugs in cerebral malaria. Trans R Soc Trop Med Hyg 1995;89:215-6.
18. Lowenstein CJ, Dinerman JL, Schnyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
19. Kremsner PG, Nussler A, Neifer S, et al. Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to development of experimental cerebral malaria. Immunology 1993;78:286-90.
20. . Rockett KA, Awburn MM, Cowden WB, Clark IA. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 1991;59: 3280-3.